Risa Tamagawa-Mineoka

Dr. Risa Tamagawa-Mineoka

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
RTRisa Tamagawa-Mineoka
Risa Tamagawa-Mineoka
YOYasutaro Okuzawa
Yasutaro Okuzawa
KMKoji Masuda
Koji Masuda
NKNorito Katoh
Norito Katoh

1 April 2010 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
RTRisa Tamagawa-Mineoka
Risa Tamagawa-Mineoka
NKNorito Katoh
Norito Katoh
SKSaburo Kishimoto
Saburo Kishimoto

Verified
Journal Article
Open access
PDF file
RTRisa Tamagawa-Mineoka
Risa Tamagawa-Mineoka
NKNorito Katoh
Norito Katoh
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease, associated with impaired skin barrier function and an atopic background. Various complicating factors, such as irritants, aeroallergens, food, microbial organisms, contact allergens, sweat, and scratching can induce the development of AD symptoms. Irritants, including soap/shampoo and clothes, can cause itching and eczematous lesions. In addition, young children with AD tend to become sensitized to eggs, milk, or peanuts, while older children and adults more often become sensitized to environmental allergens, such as house dust mites (HDM), animal dander, or pollen. Serum-specific IgE levels and skin prick test reactions to food tend to show high negative predictive values and low specificity and positive predictive values for diagnosing food allergy. On the other hand, AD adult patients tend to have severe skin symptoms and exhibit high HDM-specific IgE levels. Microbial organisms, e.g., Staphylococcus aureus and Malassezia furfur, might contribute to the pathogenetic mechanisms of AD. While sweat plays a major role in maintaining skin homeostasis, it can become an aggravating factor in patients with AD. Furthermore, scratching often exacerbates eczematous lesions. Several patient-specific complicating factors are seen in most cases. The identification and management of complicating factors are important for controlling AD.

1 January 2008 in Allergology International
Verified
Journal Article
Open access
RTRisa Tamagawa-Mineoka
Risa Tamagawa-Mineoka
NKNorito Katoh
Norito Katoh
EUEiichiro Ueda
Eiichiro Ueda
KMKoji Masuda
Koji Masuda
SKSaburo Kishimoto
Saburo Kishimoto
Beyond their role in hemostasis and thrombosis, platelets are important for modulating inflammatory reactions. Activated platelets play a role in the pathomechanism of inflammatory diseases such as asthma, but little is known about platelet activation in chronic skin inflammation, including atopic dermatitis (AD) and psoriasis. Furthermore, the relationship between platelet activation and disease severity is not understood. This work was performed to investigate plasma levels of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) as platelet activation markers in patients with AD or psoriasis, and to determine the relationships between these markers and disease severity. Plasma levels of beta-TG and PF4 were measured by enzyme-linked immunoassay in 22 healthy controls, 44 patients with AD, and 16 patients with psoriasis. The relationships between these markers and the scoring AD (SCORAD) index, blood eosinophilia, serum IgE and serum lactate dehydrogenase were investigated in AD patients, and relationships with the psoriasis area and severity index (PASI) score were examined in psoriatic patients. Plasma beta-TG and PF4 levels were significantly higher in patients with AD or psoriasis compared with healthy controls. beta-TG and PF4 levels correlated with the SCORAD index, and PF4 levels correlated with PASI scores. Elevated beta-TG and PF4 levels were significantly reduced after treatments. Our results show that blood platelets are activated in patients with AD or psoriasis, suggesting that activated platelets play a role in the pathomechanism of chronic skin inflammation. Furthermore, plasma beta-TG and PF4 may be markers for the severity of AD and psoriasis.

1 February 2015 in Journal of Dermatological Science
Verified
Journal Article
Closed access
RTRisa Tamagawa-Mineoka
Risa Tamagawa-Mineoka

1 June 2009 in Clinical Immunology
Verified
Journal Article
Closed access
RTRisa Tamagawa-Mineoka
Risa Tamagawa-Mineoka
NKNorito Katoh
Norito Katoh
EUEiichiro Ueda
Eiichiro Ueda
KMKoji Masuda
Koji Masuda
SKSaburo Kishimoto
Saburo Kishimoto